| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.6 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |